Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2008 | 12-2007 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 9,850 | 1,760 |
| Marketable Securities | 0 | 9,950 |
| Other current assets | 320 | 20 |
| TOTAL | $10,170 | $11,730 |
| Non-Current Assets | ||
| Other Non-Current Assets | 30 | 60 |
| TOTAL | $30 | $60 |
| Total Assets | $10,580 | $12,140 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 240 | 50 |
| Accrued Expenses | 1,460 | 1,030 |
| Other current liabilities | 60 | 200 |
| TOTAL | $1,770 | $1,320 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $1,770 | $1,320 |
| Shareholders' Equity | ||
| Common Shares | 1 | 1 |
| Retained earnings | -13,630 | -10,990 |
| Other shareholders' equity | -11 | -1 |
| TOTAL | $8,800 | $10,820 |
| Total Liabilities And Equity | $10,570 | $12,140 |